Shukla A, Shreshtha A, Mukund A, et al. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2021;15:531–67. https://doi.org/10.1007/s12072-021-10189-4.

Article  PubMed  Google Scholar 

Amarapurkar DN, Punamiya SJ, Patel ND. Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment. World J Gastroenterol. 2008;14:278–85.

Article  PubMed  PubMed Central  Google Scholar 

Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium-term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006;55:878–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mukhiya G, ZhouX, HanX, et al. Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis. Sci Rep. 2022;12:16166. https://doi.org/10.1038/s41598-022-20399-x.

Malakar S, Mathur A, Agarwal A, et al. Budd Chiari syndrome with portal vein thrombosis managed successfully with direct intrahepatic portosystemic shunt: A case report and review of the literature. J Clin Exp Hepatol. 2023;13:917–20. https://doi.org/10.1016/j.jceh.2023.06.005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hatzidakis A, Galanakis N, Kehagias E, et al. Ultrasound-guided direct intrahepatic portosystemic shunt in patients with Budd- Chiari syndrome: short- and long-term results. Interv Med Appl Sci. 2017;9:86–93. https://doi.org/10.1556/1646.9.2017.2.14.

Article  PubMed  PubMed Central  Google Scholar 

Amarapurkar DN, Punamiya SJ, Patel ND. Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment. World J Gastroenterol. 2008;14:278–85. https://doi.org/10.3748/wjg.14.278.

Article  PubMed  PubMed Central  Google Scholar 

Elkrief L, Payancé A, Plessier A, et al. Management of splanchnic vein thrombosis. JHEP Rep. 2023;5:100667. https://doi.org/10.1016/j.jhepr.2022.100667. 

de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74. https://doi.org/10.1016/j.jhep.2021.12.022. Erratum in: J Hepatol. 2022;: PMID: 35120736.

Shalimar, Kumar A, Kedia S, et al. Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score. Aliment Pharmacol Ther. 2016;43:1154–67. https://doi.org/10.1111/apt.13604.

Garcia-Pagán JC, Valla DC. Primary Budd-Chiari syndrome. N Engl J Med. 2023;388:1307–16. https://doi.org/10.1056/NEJMra2207738.

Article  PubMed  Google Scholar 

Valla DC. Primary Budd-Chiari syndrome. J Hepatol. 2009;50:195–203. https://doi.org/10.1016/j.jhep.2008.10.007.

Mukund A, Mittal K, Mondal A, et al. Anatomic Recanalization of Hepatic Vein and Inferior Vena Cava versus Direct Intrahepatic Portosystemic Shunt Creation in Budd-Chiari Syndrome: Overall Outcome and Midterm Transplant-Free Survival. J Vasc Interv Radiol. 2018;29:790–9. https://doi.org/10.1016/j.jvir.2018.01.781.

Article  PubMed  Google Scholar 

Jagtap N, Sharma M, Singh J, et al. Budd-Chiari syndrome: outcomes of endovascular intervention-A single-center experience. Indian J Gastroenterol. 2017;36:209–16. https://doi.org/10.1007/s12664-017-0760-6.

Pedersen MR, Molloy P, Wood D, et al. Direct intrahepatic portocaval shunt for treatment of portal thrombosis and Budd- Chiari syndrome. Ann Hepatol. 2016;15:127–30. https://doi.org/10.5604/16652681.1184288.PMID26626649.

Article  PubMed  Google Scholar 

Chandra V, Wajswol E, Shahid M, et al. Direct intrahepatic portosystemic shunt in Budd-Chiari syndrome: A case report and review of the literature. Case Rep Radiol. 2018;23:9261268. https://doi.org/10.1155/2018/9261268.

Fujiwara K, Kondo T, Fujimoto K, Koizumi J, Kato N. Percutaneous transhepatic direct portosystemic shunt for a patient with Budd-Chiari syndrome using a balloon as a target in a stenotic inferior vena cava. Cureus. 2023;15:e44967.

Hatzidakis A, Galanakis N, Kehagias E, et al. Ultrasound-guided direct intrahepatic portosystemic shunt in patients with Budd-Chiari syndrome: Short- and long-term results. Interv Med Appl Sci. 2017;9:86–93. https://doi.org/10.1556/1646.9.2017.2.14.

Article  PubMed  PubMed Central  Google Scholar 

Artru F, Moschouri E, Denys A. Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol. 2022;46:101858. https://doi.org/10.1016/j.clinre.2022.101858.

Agarwal A, Biswas S, Swaroop S, et al. Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome. World J Gastrointest Oncol. 2024;16:699–715. https://doi.org/10.4251/wjgo.v16.i3.699.

Article  PubMed  PubMed Central  Google Scholar 

Malakar S, Pande G, Mishra P, et al. Incidence of hepatocellular carcinoma in patients with autoimmune liver disease in India. J Clin Exp Hepatol. 2024 ;14:101357. https://doi.org/10.1016/j.jceh.2024.101357.

Darcy M. Evaluation and management of transjugular intrahepatic portosystemic shunts. AJR Am J Roentgenol. 2012;199:730–6. https://doi.org/10.2214/AJR.12.9060. Erratum. In: AJR Am J Roentgenol. 2013;200:232.